Concerns about andexanet
Blood Coagul Fibrinolysis
.
2017 Jun;28(4):275.
doi: 10.1097/MBC.0000000000000624.
Authors
Claudia Stöllberger
1
,
Birke Schneider
Affiliation
1
a2nd Medical Department, Krankenanstalt Rudolfstiftung, Vienna, Austria bMedizinische Klinik II, Sana Kliniken Lübeck, Lübeck, Germany.
PMID:
28177945
DOI:
10.1097/MBC.0000000000000624
No abstract available
Publication types
Comment
MeSH terms
Administration, Oral
Anticoagulants*
Factor Xa Inhibitors*
Humans
Substances
Anticoagulants
Factor Xa Inhibitors